Dysregulation of β-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma

Dysregulation of β-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma
复制标题

DOI:
10.1245/aso.2003.05.003
复制
发表时间:
2003-04-01
影响因子:
3.7
通讯作者:
Groden, J
Groden, J
中科院分区:
医学2区
文献类型:
--
作者:
Lowy, AM;Fenoglio-Preiser, C;Groden, J

文献摘要

被引文献

相似文献

背景:β-连环蛋白作为E-钙粘蛋白/连环蛋白粘附复合物的一个组成部分,维持上皮细胞的完整性。β-连环蛋白也作为Wnt信号转导途径的一部分发挥作用,通过与Tcf/Lef转录因子的相互作用将促生长信号传递到细胞核。以前的报告已经证明了改变β-连环蛋白的表达在许多肿瘤类型,但是,关于β-连环蛋白的表达在胰腺癌的报告一直conflicted.Methods:β-连环蛋白的表达进行了检查,在10个胰腺癌细胞系的Western和北方分析和免疫荧光。结果:10株胰腺癌细胞系中有4株β-catenin表达降低。在32例胰腺癌(56%)中观察到膜表达减少,并与肿瘤分化丧失相关。在两个肿瘤(4%)中发现了细胞核β-连环蛋白表达。β-连环蛋白表达存在于所有7个病灶的原位癌,然而,核表达是主要的7 cases.Conclusions:β-连环蛋白表达的改变是常见的胰腺癌,然而,信号和粘附功能可能会在不同的时间在肿瘤进展过程中受到干扰。因此,β-连环蛋白的失调可能通过不同的机制促进这种疾病的发展和进展。
Background: beta-Catenin functions as an integral part of the E-cadherin/catenin adhesion complex to maintain epithelial cell integrity. beta-Catenin also functions as part of the Wnt signal transduction pathway to transmit growth-promoting signals to the nucleus via its interactions with Tcf/Lef transcription factors. Previous reports have demonstrated altered beta-catenin expression in numerous tumor types; however, reports regarding beta-catenin expression in pancreatic cancer have been conflicting.Methods: beta-Catenin expression was examined in 10 pancreatic cancer cell lines by Western and Northern analysis and by immunofluorescence. Expression was also examined by immunohistochemistry in 57 primary pancreatic cancers and 7 foci of carcinoma-in-situ.Results: Reduced expression of beta-catenin was observed in 4 of 10 pancreatic cancer cell lines. Reduced membranous expression was noted in 32 pancreatic cancers (56%) and correlated with loss of tumor differentiation. Nuclear beta-catenin expression was identified in two tumors (4%). beta-Catenin expression was present in all seven foci of carcinoma-in-situ; however, nuclear expression was predominant in four of the seven cases.Conclusions: Alterations in beta-catenin expression are common in pancreatic cancer; however, signaling and adhesion functions may be perturbed at different times during tumor progression. Therefore, dysregulation of beta-catenin may contribute to the development and progression of this disease through distinct mechanisms.